Nootropil® (Ageing)

Other available trademarks: Nootropil®, Noostan™, Nootrop™, Nootropyl™

Nootropil® (piracetam) belongs to a family of cognition enhancing medicines called nootropics. It was first marketed for the treatment of vertigo and events associated with ageing. It is currently approved in over 100 countries for use in adults and the elderly.

Nootropil®'s main indications are in the area of psycho-organic syndromes or cognitive decline and cortical myoclonus.